A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer
Jackman, David M, Cioffredi, Leigh A, Jacobs, Lorraine, Sharmeen, Farhana, Morse, Linda K, Lucca, Joan, Plotkin, Scott R, Marcoux, Paul J, Rabin, Michael S, Lynch, Thomas J, Johnson, Bruce E, Kesari, Santosh
Published in Oncotarget (28.02.2015)
Published in Oncotarget (28.02.2015)
Get full text
Journal Article
Phase II trial of erlotinib in chemotherapy-naive women with advanced pulmonary adenocarcinoma
Jackman, D. M., Cioffredi, L., Lindeman, N. I., Morse, L. K., Lucca, J., Weckstein, D., Huberman, M. S., Lynch, T. J., Johnson, B. E., Janne, P. A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Impact of EGFR and KRAS genotype on outcomes in a clinical trial registry of NSCLC patients initially treated with erlotinib or gefitinib
Jackman, D. M., Sequist, L. V., Cioffredi, L., Ruiz, M. Gallegos, Janne, P. A., Giaccone, G., Miller, V. A., Johnson, B. E.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article